Most Read Articles
Roshini Claire Anthony, 11 Dec 2020

Treatment with the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone reduced chronic kidney disease (CKD) progression and cardiovascular (CV) event risk in patients with CKD and type 2 diabetes (T2D), according to the FIDELIO-DKD* study presented at ASN Kidney Week 2020.

Stephen Padilla, 22 Jun 2020
A dietary pattern (DP) characterized by high intakes of eggs, fish, milk, and other dairy products appears to confer protective benefits against incident cardiovascular disease (CVD) in women, reveals a study.

Linoleic acid protects against cardiovascular disease

12 Dec 2020
Statins, traditionally prescribed after myocardial infarctions or cardiac arrhythmias – are now recommended for CKD patients to reduce cardiovascular related mortality.

High plasma concentrations of linoleic acid (LA) appear to suppress several cardiovascular (CV) risk factors, reports a Norway study

The researchers conducted a cross-sectional analysis of 3,683 general-population participants (median age, 767 months, 51.3 percent male) in whom plasma fatty acids were measured by subjecting blood samples to gas chromatography. CV outcomes, such as hypertension and hypercholesterolaemia, were determined through standardized physical or laboratory tests.

Cubic spline modelling showed a linear relationship between plasma LA and CV risk factors, except for low-density lipoprotein cholesterol (LDL-C) and glycated haemoglobin (HbA1c).

Multivariable linear regression analyses confirmed significant and independent links between LA and CV risk factors. Suppressed LDL-C levels, for example, were correlated with higher plasma LA (β, –0.04; p=0.02), as were significantly lowered levels of triglyceride (β, –0.10; p<0.001).

Similarly, plasma LA was inversely associated with fasting glucose (β, –0.10; p<0.001), body mass index (β, –0.13; p<0.001), systolic (β, –0.04; p=0.03) and diastolic (β, –0.02; p=0.02) blood pressure, and estimated glomerular filtration rate (β, –0.09; p<0.001). Lowered C-reactive protein concentrations trended toward significance (β, –0.03; p=0.06).

Stratifying patients according to alcohol consumption or educational level did not substantially alter the interactions between plasma LA and CV risk factors.

“To our knowledge, this is the largest cohorts in a Norwegian general population where plasma LA levels have been measured by gas chromatography. The study population was well described and had little missing data,” the researchers said, nevertheless acceding that the study has important limitations, like its cross-sectional design and weak regression coefficients.

“Well-designed clinical trials are needed to study the effect of an increased LA intake on CV risk factors,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Dec 2020

Treatment with the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone reduced chronic kidney disease (CKD) progression and cardiovascular (CV) event risk in patients with CKD and type 2 diabetes (T2D), according to the FIDELIO-DKD* study presented at ASN Kidney Week 2020.

Stephen Padilla, 22 Jun 2020
A dietary pattern (DP) characterized by high intakes of eggs, fish, milk, and other dairy products appears to confer protective benefits against incident cardiovascular disease (CVD) in women, reveals a study.